Ferroptosis-Related Proteins Are Potential Diagnostic Molecular Markers for Patients with Preeclampsia

Meiting Shi1, Xiaofeng Yang1, Yuzhen Ding1

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinan University, Guangzhou 510000, China.

Biology
|September 14, 2022
PubMed

Insights

Preeclampsia (PE) diagnosis can be improved using ferroptosis-related genes. This study identified p53 and c-Jun as key biomarkers, with c-Jun showing superior diagnostic power for early detection and treatment.

Area of Science:

  • Biochemistry
  • Genetics
  • Reproductive Medicine

Background:

  • Preeclampsia (PE) is a major cause of maternal and fetal mortality.
  • Oxidative stress and ferroptosis are implicated in PE pathophysiology.
  • Early diagnosis of PE is crucial for reducing mortality.

Purpose of the Study:

  • To identify ferroptosis-related biomarkers for early PE diagnosis.
  • To investigate the role of ferroptosis in PE pathogenesis.
  • To validate the diagnostic value of identified genes in PE patients.

Main Methods:

  • Analysis of gene expression datasets (GEO) to identify differentially expressed genes (DEGs).
  • Utilized R package 'limma', GO, KEGG, and PPI network analysis.
  • Validated key genes (p53, c-Jun) using ELISA and ROC curve analysis.

Main Results:

  • Identified 5913 DEGs and 45 ferroptosis-related DEGs.
  • p53 and c-Jun emerged as critical hub genes in the protein-protein interaction network.
  • ELISA confirmed elevated serum p53 and decreased c-Jun in PE patients; ROC analysis showed high diagnostic accuracy (c-Jun AUC=0.87, p53 AUC=0.75).

Conclusions:

  • p53 and c-Jun are potential diagnostic biomarkers for preeclampsia.
  • These genes may play a significant role in PE development.
  • Further research into ferroptosis mechanisms in PE is warranted.